Hospice Action Network
Organization dedicated to preserving and expanding access to hospice care in America.
Based in VA
🤖
AI Overview
With $1.3M in lobbying spend across 29 quarterly filings, Hospice Action Network is a significant lobbying presence.
$1.3M
Total Lobbying Spend
29
Quarterly Filings
1
Lobbying Firms Used
3
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $131K |
| 2019 | $120K |
| 2020 | $240K |
| 2021 | $200K |
| 2022 | $200K |
| 2023 | $250K |
| 2024 | $200K |
Lobbying Firms
THE NICKLES GROUP, LLC
What They Lobby For
- Issues related to We Honor Veterans program.
- Issues concerning reimbursement for the Medicare hospice benefit. S. 1334 and H.R. 2797, Patient Choice and Quality Care Act of 2017 and issues related to advanced illness care and management. S. 980 and H.R. 1828, Rural Access to Hospice Act of 2017. S. 693 and H.R. 1676, Palliative Care and Hospice Education and Training Act. H.R. 1284 and S. 2214, Medicare Patient Access to Hospice Act of 2017. Issues related to regulatory relief. H.R. 1892, Bipartisan Budget Act of 2018, H.R. 1625, Consolidated Appropriations Act of 2018 and issues concerning patient access to hospice. H.R. 5041, The Safe Disposal of Unused Medication Act and issues regarding the disposal of unused controlled substances.
- H.R. 1892, Bipartisan Budget Act of 2018 and H.R. 1625, Consolidated Appropriations Act of 2018, as they relate to access to hospice care.
- Issues concerning reimbursement for the Medicare hospice benefit. S. 980 and H.R. 1828, Rural Access to Hospice Act of 2017. S. 1334 and H.R. 2797, Patient Choice and Quality Care Act of 2017. Issues related to advanced illness care and management. S. 693 and H.R. 1676, Palliative Care and Hospice Education and Training Act. H.R. 1284 and S. 2214, Medicare Patient Access to Hospice Act of 2017. Issues related to regulatory relief. H.R. 5041 / S. 2659, Safe Disposal of Unused Medication Act. H.R. 6, SUPPORT for Patients and Communities Act as it pertains to the disposal of unused controlled substances; S. 2661, Hospice Safe Drug Disposal Act of 2018, S.2680, Opioid Crisis Response Act of 2018 as they pertain to the disposal of unused controlled substances.
- Issues concerning reimbursement for the Medicare hospice benefit. S. 980 and H.R. 1828, Rural Access to Hospice Act of 2017. S. 1334 and H.R. 2797, Patient Choice and Quality Care Act of 2017. Issues related to advanced illness care and management. S. 693 and H.R. 1676, Palliative Care and Hospice Education and Training Act. Issues related to regulatory relief. H.R. 5041 / S. 2659, Safe Disposal of Unused Medication Act. H.R. 6, SUPPORT for Patients and Communities Act as it pertains to the disposal of unused controlled substances; S. 2661, Hospice Safe Drug Disposal Act of 2018, S.2680, Opioid Crisis Response Act of 2018 as they pertain to the disposal of unused controlled substances.
- Monitored H.R. 6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act and Continuing Appropriations Act. Monitored H.R. 695, Further Additional Continuing Appropriations Act of 2019.
- Issues related to the We Honor Veterans program.
- Issues concerning access to the Medicare hospice benefit. S. 1190 / H.R. 2594, Rural Access to Hospice Act of 2019 and issues involving access to hospice for Rural Health Clinic (RHC) and Federally Qualified Health Clinic (FQHC) patients. Issues regarding reimbursement for the Medicare hospice benefit. Issues related to advanced care illness management. H.R. 647, Palliative Care and Hospice Education and Training Act and issues regarding access to palliative care. Issues related to regulatory relief. Issues regarding program integrity. Issues regarding co-location of healthcare entities.
- S. 2080 / H.R. 647, Palliative Care and Hospice Education and Training Act and issues regarding access to palliative care.
- Issues concerning access to the Medicare hospice benefit. S. 1190 / H.R. 2594, Rural Access to Hospice Act of 2019 and issues involving access to hospice for Rural Health Clinic (RHC) and Federally Qualified Health Clinic (FQHC) patients. Issues regarding reimbursement for the Medicare hospice benefit. Issues related to advanced care illness management. Issues related to regulatory relief. Issues regarding program integrity.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.